HeiLongJiang ZBD Pharmaceutical Hits Day Low at CNY 5.87 Amid Price Pressure

HeiLongJiang ZBD Pharmaceutical Co., Ltd. experienced significant volatility on June 11, 2026, closing the day down by 8.74%. The stock reached an intraday low of CNY 5.87, reflecting ongoing challenges within the company. Over the past week, the stock has declined by 10.79%, and its performance over the past month shows a decrease of 18.38%. In a broader context, the stock has faced substantial declines over longer periods, with a staggering 47.85% drop over the past year and a 64.77% decrease over the last three years. The company's financial metrics indicate low profitability, with a Return on Capital Employed (ROCE) of just 2.85% and a Return on Equity (ROE) of -26.62%. Additionally, the company has reported negative results for three consecutive quarters, highlighting ongoing operational difficulties. With a market capitalization of CNY 6,226 million, HeiLongJiang ZBD operates within the Pharmaceuticals & Biotechnology sector, where it continues to face significant headwinds compared to the broader China Shanghai Composite index.